EchoGo® Heart Failure vs Clarius AI
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Ultromics' EchoGo® Heart Failure is an AI platform specialized in detecting HFpEF from existing echocardiograms, providing rapid diagnostic insights. In contrast, Clarius AI is an integrated suite within handheld ultrasound scanners, enhancing real-time image acquisition, quality, and measurement automation across various specialties. While both utilize AI in medical imaging, EchoGo® focuses on post-acquisition diagnostic analysis for a specific condition, whereas Clarius AI provides real-time assistance during the ultrasound scanning process itself.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGou00ae Heart Failure is an AI platform specifically designed to analyze routine echocardiograms for the detection of Heart Failure with preserved Ejection Fraction (HFpEF), providing diagnostic insights within 20 minutes. Clarius AI, conversely, is a suite of AI features integrated into handheld ultrasound scanners and an app, aimed at enhancing image quality, automating measurements, and offering real-time guidance across various specialties during the scanning process.
EchoGou00ae Heart Failure analyzes routine echo video clips, meaning it integrates with existing echocardiography machines by processing their output. Clarius AI is directly integrated into Clarius Mobile Health's handheld ultrasound scanners, which are wireless and ultra-portable, and operates via a mobile application.
EchoGou00ae Heart Failure is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis, and is also covered in the hospital inpatient setting. Clarius AI involves purchasing Clarius HD3 scanners, which start at $2,995 USD, along with an annual membership of $595 USD, or a one-time purchase starting at $4,900 USD with add-ons a la carte. The membership unlocks advanced software, AI tools, and DICOM/PACS integration.
EchoGou00ae Heart Failure is clinically validated with 90% sensitivity and 86% specificity for HFpEF and was trained on over 10 years of outcome data. It has also undergone rigorous real-world testing and external validation. Clarius AI is FDA-cleared, with specific AI applications like Clarius Prostate AI, MSK AI, Bladder AI, and OB AI also receiving FDA clearance for various measurement and guidance functions.
EchoGou00ae Heart Failure is designed for seamless integration with existing workflows and IT stacks, utilizing a DICOM workflow for report delivery to PACS. Clarius AI integrates with the Clarius Cloud for unlimited storage and offers DICOM/PACS integration with its membership, operating through a mobile application on iOS/Android devices.
Clarius AI offers real-time features such as Auto Preset AI for image optimization, real-time AI labeling and anatomical overlays (T-Modeu2122) for guidance during scans, and semi-automatic measurements. EchoGou00ae Heart Failure focuses on post-acquisition analysis, providing insights from routine echo video clips within 20 minutes to support clinical decisions.